Pharmaceutical Business review

Synergetics signs new agreement with Codman & Shurtleff

Under the terms of the new agreement, Codman will continue to market and distribute certain bipolar generators and related disposables and accessories supplied by Synergetics.

Additionally, Synergetics and Codman extended the licensing agreement providing for the continued licensing of Synergetics’s Malis trademark to Codman for use with certain of its products, including those covered by the distribution agreement.

David Hable, president and CEO of Synergetics USA, said: “We are pleased to announce our new agreement with Codman. Through the efforts of both our organizations, we have successfully partnered on this contract to ensure improved service, efficient production planning, and close collaboration on product development in order to exceed customer needs and speed new products to market. Codman is an important and valued partner of Synergetics and we look forward to our continued relationship under this agreement.”